1. Introduction {#sec1-genes-10-00876}
===============

Among the earliest tissues formed during embryonic development are epithelia, the thin, cellular layers that line the surfaces of all organs and body cavities. More than just semi-permeable "barriers", epithelia are, in fact, highly dynamic tissues, actively regulating embryonic growth and expansion, as well as providing essential biochemical and mechanical signal-transduction cues. Understanding the nature of the genetic networks that regulate normal epithelial development is therefore a cornerstone of understanding birth defects due to epithelial aberrations. These not only include significant congenital abnormalities, (e.g., neural tube defects, cleft lip/palate, intestinal dysfunction), but, importantly, also underpin numerous epithelial disorders in later life (e.g., psoriasis, eczema, ectodermal dysplasia and, critically, cancers). Therefore, identifying the genes that drive epithelial formation and maintenance is a necessary first step to developing therapies that may ultimately ameliorate both the severity and incidence of congenital and adult onset epithelial pathologies.

Among the most critical genes for epithelial development and homeostasis are the highly conserved *Grainyhead-like* (*Grhl*) transcription factors. First described in *Drosophila* \[[@B1-genes-10-00876]\] as *grainyhead* (*grh*), this gene family is found in all organisms within the animal kingdom, and is remarkable both for its extremely high evolutionary conservation across eukaryotes \[[@B2-genes-10-00876],[@B3-genes-10-00876]\], and for the extensive and disparate functions that are controlled by its various orthologues, in the context of both embryonic development and adult onset disease. In *Drosophila*, *grh* regulates key processes of epithelial development, such as Planar Cell Polarity (PCP), formation of the chitinous head "skeleton", dorsal hole closure, and cuticle integrity and maintenance \[[@B1-genes-10-00876]\], whereas fungal *Grhl* is essential for cell wall remodelling and asexual spore (conidial) separation \[[@B4-genes-10-00876]\]. In vertebrates, *Grainyhead-like* orthologues display a conserved functional homology of regulating processes, required for epithelial development. Studies in mice \[[@B2-genes-10-00876],[@B5-genes-10-00876]\], *Xenopus* \[[@B6-genes-10-00876]\] and zebrafish \[[@B7-genes-10-00876]\] have determined remarkable conserved functional homology to *Drosophila grh*, apparent in the morphogenic development of the epidermal barrier \[[@B8-genes-10-00876],[@B9-genes-10-00876],[@B10-genes-10-00876],[@B11-genes-10-00876]\], closure of the neural tube \[[@B12-genes-10-00876],[@B13-genes-10-00876],[@B14-genes-10-00876],[@B15-genes-10-00876]\], maintenance of neural cell survival \[[@B16-genes-10-00876]\], and the growth and development of the craniofacial skeleton \[[@B17-genes-10-00876],[@B18-genes-10-00876]\]. Together, these findings point to a critical role for *Grhl* function in the development of all organisms within the animal kingdom.

Recent work has also shown that *Grhl* function is highly conserved in humans, and that these genes regulate both development and adult disease. Critical recent work has demonstrated that loss of *GRHL3* leads to the craniofacial defect Van der Woude Syndrome (VWS), characterised by clefting of the secondary palate. This anomaly is due to aberrant maintenance of the oral periderm, a thin, extra-epithelial tissue that lines the developing palatal shelves \[[@B19-genes-10-00876]\]. Additionally, *GRHL3* mutations are also associated with non-syndromic palatal clefting \[[@B20-genes-10-00876]\] and spina bifida \[[@B21-genes-10-00876]\]. As substantial, disparate craniofacial defects are also observed in *Drosophila*, zebrafish and murine models lacking *grh/Grhl2/Grhl3* function, and, as these factors are expressed almost exclusively in epithelia, it becomes clear that both clefting and other facial, jaw and skull deformities observed in these models are secondary to a primary epithelial defect, following abrogation of *grh/Grhl* function.

After development, *Grainyhead-like* (*Grhl*) plays an important a role in regulating genes required for the maintenance of the epithelial barrier during growth and injury. Studies of human *Grainyhead-like* (*Grhl*) orthologues have begun to uncover the role that loss of function or gene variants have in adult-onset diseases, such as hearing loss/deafness \[[@B22-genes-10-00876],[@B23-genes-10-00876]\], defects of epidermal integrity and, particularly, numerous forms of cancer \[[@B9-genes-10-00876],[@B24-genes-10-00876],[@B25-genes-10-00876],[@B26-genes-10-00876]\]. The *Grhl*-genes are also implicated in the aetiology of a number of human diseases, including cleft palate \[[@B27-genes-10-00876],[@B28-genes-10-00876]\], spina bifida \[[@B5-genes-10-00876],[@B14-genes-10-00876],[@B29-genes-10-00876]\], cancer \[[@B30-genes-10-00876]\], ectodermal dysplasia \[[@B28-genes-10-00876]\] and asthma \[[@B31-genes-10-00876]\]. This incredible functional diversity is mediated, at least in part, through a *grh*/*Grhl* transcription factor binding to a promoter or enhancer element and regulating the subsequent transactivation or repression of target effector genes through recruitment of transcriptional co-factors.

The *grh*/*Grhl* binding site is exceptionally well-conserved through evolution, broadly taking the form AA**[C]{.ul}**CG**[G]{.ul}**TT (with the first "C" and second "G" largely invariant in experimentally validated assays). Although several upstream regulatory factors, such as branchless/FGF8 and Erk \[[@B32-genes-10-00876],[@B33-genes-10-00876]\], and interacting co-factors, such as LMO4 \[[@B10-genes-10-00876],[@B34-genes-10-00876]\], have been described, the delineation of *grh*/*Grhl*-dependent transcriptional networks has largely focussed on the identification and characterisation of these direct downstream target genes. Many candidate genes have been experimentally validated in the literature, both through targeted approaches (e.g., *Tgm1*/5 \[[@B35-genes-10-00876]\], *ARHGEF19* \[[@B36-genes-10-00876]\], *Dsg1* \[[@B37-genes-10-00876]\], *eng2a* \[[@B16-genes-10-00876]\], *spec1* \[[@B16-genes-10-00876]\], *edn1* \[[@B17-genes-10-00876]\] and *PTEN* \[[@B30-genes-10-00876]\], and, more recently, through large-scale screening approaches, such as RNA-SEQ and ChIP-SEQ. However, the precise mechanisms by which the *grh/Grhl*-dependent transcriptome regulates numerous disparate cellular and developmental functional processes are still unclear. Nevertheless, it is clear that the functional interaction between *grainyhead*-signalling and target gene regulation is dependent on tissue, and developmental/disease stage and organism, and the incredible heterogeneity of these regulations suggest that delineation of these *grh*/*Grhl* transcriptional networks will shed significant light on both embryonic development and disease.

Currently, 41 Microarray/RNA-SEQ datasets probing Grhl function have been reported in the literature, from both *Drosophila* and mouse tissues, as well as several human cancer/short-hairpin RNA (shRNA) cell lines ([Table 1](#genes-10-00876-t001){ref-type="table"}). In order to delineate the *grh*/*Grhl* transcriptional network, we have interrogated these datasets to bring greater clarity to the *Grainyhead*-dependent transcriptome, and to begin to understand the critical effector genes that operate broadly across disparate contexts, as well as identifying those that have more restricted roles in specific processes, particularly epithelial development.

Lastly, using our recently described *grhl3^-/-^* zebrafish that present with epithelial defects of the enveloping layer, EVL \[[@B7-genes-10-00876]\], we performed Q-RT-PCR to determine the expression of zebrafish orthologues of the ten most differentially regulated epithelial genes, thereby functionally testing the predictive strength of our meta-analysis approach in a novel animal model. Together, this study collates multiple "big-data" approaches and provides an experimental pipeline for determining and testing novel *grh/Grhl*-dependent functional interactions.

2. Methods {#sec2-genes-10-00876}
==========

2.1. RNA-SEQ and Microarray Meta-Analysis and Database Construction {#sec2dot1-genes-10-00876}
-------------------------------------------------------------------

The datasets from individual studies were converted to a common file format (.csv) and imported into MySQL ([www.mysql.com](www.mysql.com)), a relational database management system that enables the identification of relationships between datasets. Inside the database, the data were combined into species-specific tables. Using information from Ensembl v.91, gene symbols from the original human data files were mapped to the human Ensembl gene_stable_ids; gene symbols from other species were mapped to human gene symbols and gene_stable_ids of their orthologous human genes. After mapping, all the human-mapped data were joined together into a single table, searchable by the original gene symbol in every species, as well as the gene symbol and gene_stable_id of the human orthologue, publication name, dataset name, type of *Grhl* regulator, and direction of *Grhl* regulation (positive or negative), and were designated as being derived from either "cell-line" or "tissue". For interactive visualization and exploring, the data were exported from the MySQL database, re-structured and uploaded into the Ordino tool (<https://ordino.caleydoapp.org>). To achieve a common gene ranking, the fold change rank-based scores from individual datasets were aggregated into the sum of scores for each gene, separately for positively and negatively regulated genes. For datasets where p-values/false discovery rates (FDRs) were available, another set of scores, based on p-value/FDR ranks, and computed independently for positively and negatively regulated genes, are also available. For singular genes, and the direction of regulation, *p*-values/FDRs from multiple datasets were combined into a single p-value, using the standard Fisher's method. The ranks were then transformed into normalised scores that permitted aggregation of rank-based information from datasets comprising different numbers of genes. In order to do this, we used a scoring function f(r) =1/r\^k, where k was an arbitrary parameter, allowing us to determine the significance of a genes' rank across datasets. The constant of k = 3 was chosen, as it balanced the number of datasets that a given gene appeared in with instances in which this gene was highly ranked within an individual dataset. Therefore, the top ranked gene (Rank \#1) within a given dataset would achieve a normalised score of 1 (1/1\^3), whereas, if a gene did not appear within a particular dataset, it would be given a score of 0.

2.2. Zebrafish Experimentation {#sec2dot2-genes-10-00876}
------------------------------

All zebrafish experiments were conducted in accordance with La Trobe University guidelines for the care and housing of zebrafish, under Animal Ethics Committee approval number AEC16-91. The *grhl3^-/-^* fish line was reported previously \[[@B7-genes-10-00876]\].

2.3. RNA Extraction and cDNA Synthesis {#sec2dot3-genes-10-00876}
--------------------------------------

RNA was isolated from *grhl3^-/-^* and wild type embryos (at 48 hours post-fertilisation; hpf) as described previously \[[@B38-genes-10-00876]\]. cDNA was synthesized (from three biological replicates, using WT and phenotypic *grhl3^-/-^* embryos at 48hpf, utilising 50 embryos per group per replicate) using the iScript™ cDNA (Life Science Research, Bio-Rad, Hercules, CA, USA) synthesis kit, according to the manufacturer's instructions. Quantitative Reverse Transcription Polymerase Chain Reaction (Q-RT-PCR) using SsoFast™ EvaGreen® Supermix (Bio-Rad) and a BioRad CFX96 Real-Time System/C1000 Thermal Cycler was employed to quantify expression levels of 10 genes (comprising 17 fish orthologues) that were predicted to be differentially regulated in epithelial establishment following loss of *grhl3*, using methodology described previously \[[@B38-genes-10-00876]\]; expression levels were normalised to the EF1α housekeeping gene, as described previously \[[@B7-genes-10-00876]\]. Oligonucleotide sequences used for Q-RT-PCR are shown in [Table S1](#app1-genes-10-00876){ref-type="app"}.

3. Results {#sec3-genes-10-00876}
==========

3.1. Meta-Analysis Reveals the Most Consistently Differentially-Regulated Genes Following grh/Grhl Misexpression {#sec3dot1-genes-10-00876}
----------------------------------------------------------------------------------------------------------------

In order to analyse the *grh*/*Grhl* transcriptome across multiple disparate biological contexts, we standardised all published *grh/Grhl* Microarray/RNA-SEQ datasets into a common format that allowed for direct comparison of differing methodologies and results, together with the corresponding published fold-changes and p-values ([Figure 1](#genes-10-00876-f001){ref-type="fig"}). Differences in methodologies and data reporting in published studies created the need to integrate lists of regulated genes that were of different lengths, selected using different (study-specific) criteria. As studies varyingly examined the effects of either loss or gain of function of *grh*/*Grhl*, we divided the data based on whether a gene was positively or negatively regulated under normal homeostatic conditions. That is, if a gene was found to be downregulated in an experimental paradigm following loss of *grh/Grhl*, we deemed it to be positively regulated. Next, the positively and the negatively regulated genes were separately ranked, on the basis of the reported fold-change within each dataset ([Figure 1](#genes-10-00876-f001){ref-type="fig"}).

Our analysis allowed us to determine the genes that are both most frequently and most substantially differentially regulated, following gain/loss of *grh/Grhl* function. From these comparisons, we determined which genes exhibited the greatest degree of regulation following disruption of grh/*Grhl* signalling. We determined this by: (1) frequency of altered expression (the number of datasets a given gene appeared in as "regulated"); and (2) degree of regulation, measured by the score, based on the rank given to a gene in a particular dataset, with respect to other differentially regulated genes. These analyses allowed us to reveal the genes that appeared within at least one dataset and determine the top differentially regulated genes following grh/Grhl de-regulation or misexpression, across all biological contexts thus far tested and described in the literature ([Figure 2](#genes-10-00876-f002){ref-type="fig"}).

From these analyses, we compiled a list of the top 50 most-highly differentially regulated genes (following *grh/Grhl* modulation) across various tissues and cell lines, and at different developmental time points ([Table 2](#genes-10-00876-t002){ref-type="table"}). As *grh/Grhl* transcription factors bind to the promoter of target genes in order to drive transcription, we determined whether any of these genes had previously been identified as being bound by *grh/Grhl* factors in ChIP or ChIP-SEQ datasets. In total, 15 of the top 50 genes in our list (30%: *tmem54, prom2, cldn4, ppl, cdh1, rab15, lad1, rab25, Epcam, Tacstd2, st14, Esrp1, Prss22, spint1* and *prss8*) are known to be bound to *grh/Grhl* factors, supporting the robustness of our analysis algorithm. Additionally, seven genes in our list---*cldn4, rab15, rab25, epcam, cdh1, tslp,* and *spint1---*had been previously characterised as direct *Grhl*-target genes through biological validation experiments, further highlighting the predictive strength of our approach.

3.2. Biological Pathways Regulated by grhl in Epithelia as Identified by GO Analysis {#sec3dot2-genes-10-00876}
------------------------------------------------------------------------------------

In order to determine the overall biological processes regulated by the grh/*Grhl* pathway, we performed GO (Gene Ontology) pathway analysis, using gProfiler's GOStat (Gene Group Functional Profiling), with the default background set of all human genes. Mindful of obvious limitations, such as tissue origin, disease state and temporal/developmental time point, we nonetheless analysed all the disparate datasets to determine an "overall" snapshot of *grhl*-target gene biology ([Table 3](#genes-10-00876-t003){ref-type="table"}). We found that this analysis largely confirmed previous known roles of the *Grhl* family. The major biological functions ascribed to genes regulated by the *Grhl* family were "cell--cell adhesion" "tissue (epithelia/epidermis) development", "animal organ/skin development", "water homeostasis" and "epithelial cell morphogenesis", consistent with known *grh/Grhl*-dependent functions in epithelial morphogenesis and maintenance, as well as preventing trans-epidermal water loss and maintaining epithelial integrity through suppressing the epithelial--mesenchymal transition (EMT). Somewhat surprisingly, the GO term "protein cross-linking" was also highlighted in our *grh/Grhl* transcriptome analysis. *grh/Grhl* factors are thought to be constitutively bound to the promoters/enhancers of target genes, achieving transcriptional specificity through the recruitment of partner protein co-activators as development proceeds \[[@B39-genes-10-00876]\]. These co-factors may include members of the Polycomb and Trithorax groups in Drosophila \[[@B39-genes-10-00876],[@B40-genes-10-00876]\], and the vertebrate transcription factor LMO4 \[[@B34-genes-10-00876]\] in mice, although, as few such co-factors are known, enrichment of this GO term may suggest a novel, hitherto unsuspected *grh/Grhl* role in the assembly, formation or maintenance of the core transcriptional apparatus.

3.3. Grhl-Dependent Target Genes are Well-Conserved between Mouse and Human; Less so between Mouse and Drosophila {#sec3dot3-genes-10-00876}
-----------------------------------------------------------------------------------------------------------------

In order to determine how well conserved the *grh/Grhl*-dependent transcriptional pathways were between mouse, *Drosophila* and human, we generated separate lists for each organism, using only species-specific, large-scale microarray/RNA-SEQ datasets. This analysis comprised 20 datasets from mouse, six datasets from *Drosophila*, and 12 datasets from human ([Table 1](#genes-10-00876-t001){ref-type="table"}). Using the top 50-ranked mouse genes as our root list for comparison, we determined which of these genes were ranked in the top 10% differentially-regulated genes in both *Drosophila* (in the top 1300 of \~13,000 genes in the *Drosophila* genome) and human (top 2500 out of \~25,000 total human genes), reasoning that genes which fell below this ranking threshold were less likely to be biologically-relevant in the context of *grh/Grhl* transcription ([Table 4](#genes-10-00876-t004){ref-type="table"}). Our analyses showed that 32 of the top 50 mouse genes had an identifiable *Drosophila* orthologue, with 4/32 orthologues of these mouse genes---*Grhl2 (grh), Car6 (CAH7), Car2 (CAH1)* and *unc93a (GC4928)---*also being differentially-regulated in *Drosophila*. Unsurprisingly, the degree of conservation was greater in human, with 47/50 human orthologues identified, and 17/47 of these mouse targets appearing in the top 10% differentially regulated human genes. Moreover, 13 of these orthologues---*PROM2, CLDN4, PPL, GRHL2, CDH1, LAD1, RAB25, TMPRSS13, AP1M2, KLK6, SFN, CLDN1* and *RPTN*---appeared within the top 500 (top \~2%) most differentially regulated genes in humans, suggesting that these genes may substantially underpin *Grhl*-dependent transcriptional networks in mammalian species. Analysis of these 13 genes shows that eight of these---*Prom2, Cldn4, Ppl, Cdh1, Lad1, Tmprss13, Cldn1* and *RPTN*---are involved in maintaining structural integrity within epithelia, particularly the epidermis. Of the others, there is a member of the Ras superfamily of small GTPases, involved in vesicular trafficking to the cell membrane (*Rab25*), a transcription factor (*Grhl2* itself), a serine protease (*KLK6*), a clathrin-associated adaptor in the Golgi/endosome network (*Ap1M2*) and a cell-cycle checkpoint protein (SFN). This suggests that no other biological processes are as well conserved among Grhl-differentially regulated transcripts across multiple species as epithelial and epidermal integrity. These data are particularly striking, given the large differences in the source material used to generate each of the datasets, comprising different organisms, disease states, developmental timepoints and manipulating different *grh/grhl* orthologues.

3.4. Refining Meta-Analyses to Encompass Only Large-Scale Datasets Generated from Epithelial Tissue or Cancer Cell Lines Reveals grh/Grhl-dependent Transcriptome Specificity {#sec3dot4-genes-10-00876}
-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------

As the *grh/Grhl* family are key regulators of epithelial establishment, development, maintenance and homeostasis, we refined our meta-analyses to only include datasets generated from primary epithelial tissues ([Table 1](#genes-10-00876-t001){ref-type="table"}). These data encompassed 18 datasets from seven separate publications, and restricted our data to *Grhl*-dependent transcriptomes, derived from epithelia from mouse embryonic skin \[[@B10-genes-10-00876]\], bladder \[[@B41-genes-10-00876]\], non-neural ectoderm \[[@B42-genes-10-00876]\] and lung epithelium \[[@B43-genes-10-00876]\], human neonatal epidermal keratinocytes \[[@B44-genes-10-00876]\], and undifferentiated primary human bronchial epithelial cells \[[@B31-genes-10-00876]\], as well as adult mouse and human psoriatic skin \[[@B45-genes-10-00876]\], and allowed us to identify the most-differentially regulated genes in epithelial development, the top 50 of which are shown in [Table 5](#genes-10-00876-t005){ref-type="table"}. This list includes numerous well characterized genes, known to be expressed in epithelia, which are involved in the maintenance of epithelial integrity and structural stability, such as *Claudins 1/4/23*, *Periplakin*, *Envoplakin*, *Occludin* and *Prominin 2* ([Table 5](#genes-10-00876-t005){ref-type="table"}). Interestingly, the top 50 genes include five "predicted" genes---*Gm19601*, *Gm3579*, *231000H18Rik*, *Gm20305* (possible pseudogene) and *Gm10639---*that are yet to be ascribed a function. Next, we determined which of these top 50 "epithelial" *grh/Grhl*-regulated genes may also be de-regulated in *Grhl*-influenced cancerous cells ([Table 6](#genes-10-00876-t006){ref-type="table"}). We generated a dataset of differentially regulated genes in those RNA-SEQ/Microarray datasets that were designated as being derived from "cancer cell-lines" ([Table 6](#genes-10-00876-t006){ref-type="table"}). These experiments typically included control cancer cells, compared to those in which *Grhl* activity was modulated through short-hairpin (shRNA) knockdown, and included 4T1 breast tumor cells \[[@B46-genes-10-00876]\], human mammary epithelial (HMLE-Twist-ER) cells \[[@B47-genes-10-00876]\], MSP (mesenchymal sub-population) cells obtained from HMLE cells \[[@B48-genes-10-00876]\], OVCA429 (ovarian cystadenocarcinoma; intermediate epithelial (IE) phenotype) cells \[[@B49-genes-10-00876]\] and LNCaP (human prostate carcinoma) cells \[[@B50-genes-10-00876]\]. Surprisingly, only two genes appeared in both the "epithelial targets" and "cancer targets" tables---*Tmem54* and *Claudin*-*4*, a previously experimentally validated *Grhl*-target. We did note several instances of different family members expressed across both sets (e.g., *Sod3, Krt6b/78, Tmprss4/11bnl* and *Cldn1/23/b8* in epithelia, and *Sod1/2, Krt7/19, Tmprss13* and *Cldn7* in cancer), suggesting that loss of *Grhl*-mediated transcription may lead to similar biological consequences, albeit mediated via different (possibly secondary, or indirect) target pathways. However, these results indicate that the *Grhl*-dependent transcriptome is largely context and tissue-type dependent, with little evidence of conserved mechanisms operating in epithelial homeostasis and epithelial cancer.

3.5. Expression of Differentially-Regulated Epithelial Genes in a Novel Vertebrate Model {#sec3dot5-genes-10-00876}
----------------------------------------------------------------------------------------

In order to determine the predictive power of our meta-analysis approach, to identify novel *grhl*-dependent putative target genes (both direct and indirect), we analysed the expression of our top-ranked genes that were differentially regulated in epithelia, by performing Q-RT-PCR on cDNA from *grhl3^-/-^* mutant zebrafish. This model was utilised to test our meta-analyses, as none of the large-scale datasets were generated from zebrafish tissue, hence, this model would speak to the genetic conservation of *grhl*-dependent pathways across vertebrates.

From the genes that were differentially regulated in epithelia ([Table 5](#genes-10-00876-t005){ref-type="table"}), we identified the top 10 genes with an identifiable zebrafish orthologue, or orthologues. The roles of these ten mammalian genes---*Cldn23, Ppl, Prom2, Ocln, Slc6a19, Aldh1a3, Sod3, Car6, Cldn4 and Evpl---*were sub-functionalised into a total of 17 zebrafish orthologues, based on sequence conservation homology ([Table S2](#app1-genes-10-00876){ref-type="app"}). Next, we performed Q-RT-PCR on fifty, 48 hours post-fertilisation (hpf) WT and *grhl3^-/-^* embryos (experiment performed in triplicate, see methods) to determine the relative expression of each of these fish orthologues. Of the 17 zebrafish orthologues analysed, we found that 10---*cldn23a, cldn23b, ppl, prom2, oclna, slc6a19a.1, slc6a19b, aldh1a3, sod3a* and *evplb---*showed statistically significant differences in expression between WT and *grhl3^-/-^* fish (primarily down-regulation). We utilised whole embryos for our analyses, not just epithelial tissue, and we only performed analyses at a single developmental timepoint. Nonetheless, even within these experimental constraints, the fact that 10/17 zebrafish orthologues were significantly differentially regulated highlights the remarkable conservation of *grhl*-dependent pathways across the evolutionary spectrum, and the strong predictive power of our approach for identifying novel, biologically relevant transcriptional networks downstream of g*rh/Grhl* function.

4. Discussion {#sec4-genes-10-00876}
=============

In this study, we interrogated large-scale transcriptomic data to uncover novel genetic mechanisms that operate downstream of activation or repression by *grh/Grhl* genes. We collected all currently published large-scale RNA-SEQ and microarray datasets from multiple disparate animal models, developmental timepoints, tissues and cancer cell lines, to delineate conserved *grh/Grhl*-dependent genetic networks. Using a novel, ranking-based algorithm approach to draw synergies between disparate methodologies, we identified the top-differentially regulated genes following gain or loss of grh/Grhl function in all datasets, as well as refining our analyses to the top-differentially regulated genes in primary epithelia and in cancer. We also examined the conservation of mechanisms in mouse, *Drosophila* and human genes, and, lastly, we tested the predictive strength of our meta-analysis approach to determine which of the top-ranked genes were differentially regulated in a novel vertebrate grhl-loss-of-function model, the zebrafish. Taken together, our study brings cohesion and clarity to the existing "big-data" approaches to tackle grh/Grhl-dependent transcription, and opens up new avenues (and identifies novel putative targets) to further experimentally delineate *grh/Grhl*-dependent transcriptional genetic regulatory networks.

Across the 41 disparate Microarray/RNA-SEQ datasets, of the top 50 genes we identified, 15 had previous connections to *Grhl* transcription factors, either through ChIP/ChIP-SEQ experiments to identify regions of genome occupancy by *Grhl* proteins, or through targeted biological experiments to empirically determine novel functional relationships. The genes to which *Grhl*-factors bind, and drive/repress transcription can be considered true "direct" target genes. A number of our top 50 genes fall into this category, namely, *Cldn4, Cdh1 (E-Cadherin), Rab25, Epcam, Esrp1* and *Spint1,* with a further nine genes---*Tmem54, Prom2, Ppl, Lad1, Tacstd2, St14, Prss22,* and *Prss8---*showing instances of promoter-binding by *Grhl*-factors in ChIP-analyses, but currently lacking empirical experimental validation to determine true biological interactions. As such, these nine genes would appear to be the prime candidates for future studies into identifying novel *Grhl*-target genes through established analyses, such as in vitro luciferase activation assays, genetic complementarity in animal models (e.g., through generating *Grhl*/gene-of-interest doubly heterozygous mice) or models to rescue *Grhl* loss-of function phenotypes, as we have shown previously by rescuing aberrant developmental phenotypes in *grhl2b* or *grhl3*-deficient zebrafish embryos, with *eng2a* \[[@B16-genes-10-00876]\] and *edn1* \[[@B17-genes-10-00876]\] mRNA micro-injection, respectively.

The *Grhl*-family are well-known in both embryogenesis and cancer. Multiple studies have highlighted substantial developmental abnormalities in animal models lacking *Grhl* factors. These include numerous skin formation, maintenance and healing defects \[[@B2-genes-10-00876],[@B11-genes-10-00876],[@B28-genes-10-00876],[@B36-genes-10-00876],[@B51-genes-10-00876]\], impaired neural tube closure \[[@B5-genes-10-00876]\], facial and palatal clefting \[[@B19-genes-10-00876],[@B52-genes-10-00876]\], regulation of skull bone apposition \[[@B18-genes-10-00876]\] and impaired formation of the lower jaw \[[@B17-genes-10-00876]\]. These latter (craniofacial) defects are interesting, owing to the fact that they are secondary consequences of disrupted epithelial formation---either the overlying cranial skin not allowing cranial bones to grow and expand \[[@B18-genes-10-00876]\], or through decreased endodermal *edn1*-signalling from the endodermal epithelium to cranial neural crest cells \[[@B17-genes-10-00876]\]. These studies parallel recent findings in human craniofacial disorders, namely Van der Woude Syndrome (VWS), a congenital syndrome characterised by palatal clefting. Disruption of the thin epithelial layer covering the developing palatal shelves---the periderm---leads to clefting in both mice and humans due to adhesions forming between the palatal shelves and tongue in utero \[[@B19-genes-10-00876]\]. Critically, VWS is also known to be caused by mutations in a critical *Grhl*-co-factor, IRF6 \[[@B53-genes-10-00876]\] in both mice and humans. These studies show that understanding the *Grhl*-dependent transcriptome is likely to uncover further novel biological pathways in the aetiology of craniofacial (and other epithelial) disorders caused by a primary epithelial defect.

In the context of cancer, *Grhl*-factors perform tumor-suppression roles in the epithelia of both the skin \[[@B30-genes-10-00876]\] and oesophagus \[[@B54-genes-10-00876]\], as well as maintaining epithelial identity through suppression of the epithelial--mesenchymal transition (EMT) in cancers of epithelial origin \[[@B47-genes-10-00876]\]. Strikingly, and somewhat surprisingly, our study found virtually no correlation between the top 50 differentially regulated genes in normal epithelia as compared to cancerous cells, with only two genes---*Tmem54* and *Claudin4---*appearing in both lists. This could suggest that, in general terms, the normal *grh/Grhl-*dependent transcriptional pathways, that operate in epithelial development, homeostasis and maintenance, are not the most highly dysregulated in epithelial cancers. Caveats exist in this interpretation, chief among them being the lack of a direct comparison between normal and cancerous epithelia derived from the same source, as well as the substantial differences that exist between cells and tissues of origin utilised for the individual RNA-SEQ/Microarray datasets. Additionally, the published microarray/RNA-SEQ datasets defining the role of Grhl in cancers follow the experimental paradigm of inhibiting or over-expressing Grhl-factors in already tumorigenic cell lines, which is a separate biological question to analysis of the transcriptome of cancers that arise directly due to aberrant *Grhl*-function. Transcriptomic analyses of tumors arising in Grhl3-deficient mice, relative to non-cancerous adjoining tissue, such as the skin and esophagus \[[@B30-genes-10-00876],[@B54-genes-10-00876]\], would add important data points to our current meta-analyses.

Overall, this study demonstrates that meta-analysis of previously published RNA-Seq datasets is able to identify novel targets of *grhl* transcription. The depth and robustness of this approach is clearly demonstrated by the fact that many of the genes identified via this method have been previously validated in the literature. Moreover, the experimental validation of altered expression of our identified target genes, using a vertebrate model that was not included in any of the published data sets, highlights the power of this type of analysis to predict conserved gene targets across different model organisms. Our experimental paradigm naturally has certain caveats and limitations, which any analysis must keep in mind, such as the degree and direction of target regulation in fish compared to mammals, the analysis of gene expression over separate developmental and, perhaps, adult timepoints, and specific analyses through ISH/IHC of mRNA/protein distribution, specifically in epithelial tissues, e.g., developing EVL and the skin. Moreover, grh (and presumably also Grhl) proteins are known to be post-translationally modified through processes such as phosphorylation \[[@B32-genes-10-00876],[@B55-genes-10-00876]\], which further confounds the precise nature of grh/Grhl-dependent regulation (or co-regulation) of transcriptional targets. Nonetheless our experimental approach in fish successfully identified 10 gene orthologues that are significantly differentially regulated, as predicted by the meta-analysis database construction algorithms we have developed and utilised here. Lastly, our analyses did not determine which of these genes may be true direct targets, based on promoter occupancy of the target gene promoter by grh/Grhl, although such direct binding and activation/repression approaches would be a logical extension of our meta-analyses. Thus, our database is an excellent resource for researchers in the field of grhl function, helping to identify and categorise novel molecular pathways underlying various developmental and disease processes.

The following are available online at <https://www.mdpi.com/2073-4425/10/11/876/s1>, **Table S1:** Oligonucleotide sequences used in the present study; **Table S2:** Zebrafish orthologues of differentially regulated mammalian genes. The top 10 differentially regulated genes following *Grhl*-dependent modulation in primary epithelia that had identifiable zebrafish orthologues, showing the function of each gene in mammals. Zebrafish orthologues of these ten mammalian genes comprise a total of 18 separate genes.
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Click here for additional data file.
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![**Meta-analysis pipeline methodology** All published *grh/Grhl* Microarray/RNA-SEQ datasets were converted to a common file format (.csv, **A**) and imported into MySQL (**B**). Next, we determined whether genes within each dataset were positively or negatively regulated following functional modulation of *grh/Grhl* (**C**), and genes across the datasets were ranked according to their regulation within each dataset. To achieve a common gene ranking, the fold change rank-based scores from individual datasets were aggregated into the sum of scores for each gene, separately for positively and negatively regulated genes. (**D**). Each gene symbol within all datasets was mapped to the appropriate gene using Ensembl. After mapping, a table of all the human-mapped data was generated, searchable by the original gene symbol in every species (**E**). For interactive visualization and exploring, the data were exported from the MySQL database, re-structured and uploaded into Ordino (**F**).](genes-10-00876-g001){#genes-10-00876-f001}

![Q-RT-PCR analysis of zebrafish orthologue expression in 48 hours post-fertilisation (hpf) WT and *grhl3*^-/-^ embryos. Gene expression was normalised to expression of housekeeping gene EF1a. Of the 18 fish orthologues selected, 10 showed differential expression in WT (black bars) vs *grhl3^-/-^* (white bars) embryos. \* *p* \< 0.05, \*\* *p* \< 0.01, n.s., non-significant.](genes-10-00876-g002){#genes-10-00876-f002}
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Published datasets used for meta-analysis. Microarray and RNA-SEQ datasets including tissue of origin were classified as being derived from either "primary epithelia", "cell line---cancer", "cell line---non-cancer", "other mammalian" or "other non-mammalian", for subsequent analyses.

  ------------------- --------------------------- -------------------------------------------------------------------------------- ----------------------------------------------------------------------- ------------------------------------------ --------------------------------------------------------
  **Gene**            **Species**                 **Dataset**                                                                      **Tissue/Cell Line**                                                    **Classification/Origin**                  **Reference**
  *grh*               *Drosophila melanogaster*   1                                                                                2--3 hour whole embryos                                                 Other - non-mammalian                      Nevil et al., *Genetics*, 2017
                      2                           11--12 hour whole embryos                                                        Other - non-mammalian                                                   Nevil et al., *Genetics*, 2017             
                      3                           15--16 hour whole embryos                                                        Other - non-mammalian                                                   Nevil et al., *Genetics*, 2017             
                      4                           13--16 hour whole embryos                                                        Other - non-mammalian                                                   Yao et al., *Development*, 2017            
                      5                           13--16 hour whole embryos                                                        Other - non-mammalian                                                   Yao et al., *Development*, 2017            
                      6                           Stage 16--17 whole embryos                                                       Other - non-mammalian                                                   Yao et al., *Development*, 2017            
  *Grhl*              *Neurospora crassa*         7                                                                                48 hour aerial hyphae and conidia                                       Other - non-mammalian                      Pare et al., *PLoS ONE*, 2012
  *Grhl2*             *Mus musculus*              8                                                                                E9.5 Non-neural ectoderm                                                Primary Epithelia                          Ray et al., *Development*,2016
                      9                           E16.5 Lung epithelium                                                            Primary Epithelia                                                       Kersbergen et al., *Dev. Biol*., 2018      
                      10                          E16.5 Lung epithelium                                                            Primary Epithelia                                                       Kersbergen et al., *Dev. Biol*., 2018      
                      11                          E9.5 Cranial tissue                                                              Other - mammalian                                                       Pyrgaki et al., *Dev. Biol*., 2011         
                      12                          Extraembryonic trophectoderm-derived tissues at E7.5                             Other - mammalian                                                       Walentin et al., *Development*, 2015       
                      13                          E9.5 Placenta                                                                    Other - mammalian                                                       Walentin et al., *Development*, 2015       
                      14                          E9.5 First pharyngeal arch (PA1)                                                 Other - mammalian                                                       Carpinelli et al., *submitted*, 2019       
                      15                          Immortalised Mouse Lung Epithelial Cells (MLE15)                                 Cell line - Non-Cancer                                                  Varma et al*., J. Biol. Chem*., 2012       
                      16                          NIH3T3 fibroblast cells                                                          Cell line - Non-Cancer                                                  Werner et al., *J. Biol. Chem*., 2013      
                      17                          IMCD-3 (inner medullary collecting duct) cell line                               Cell line - Non-Cancer                                                  Aue et al., *J AmSoc Nephrol*, 2015        
  *Grhl2*             *Canis familiaris*          18                                                                               Madin-Darby Canine Kidney (MDCK) cells                                  Cell line - Non-Cancer                     Pifer et al., *Mol. Biol. Cell*, 2016
                                                  19                                                                               Madin-Darby Canine Kidney (MDCK) cells                                  Cell line - Non-Cancer                     Pifer et al., *Mol. Biol. Cell*, 2016
  *Grhl2*             *Homo Sapiens*              20                                                                               \"Early Passage\" Primary Normal Human Epidermal Keratinocytes (NHEK)   Primary Epithelia                          Chen et al., *Cell Death Dis*., 2012
                      21                          \"Late passage\" NHEK                                                            Primary Epithelia                                                       Chen et al., *Cell Death Dis*., 2012       
                      22                          Undifferentiated primary human bronchial epithelial cells                        Primary Epithelia                                                       Gao et al., *PNAS,* 2014                   
                      23                          4T1 breast tumour cells                                                          Cell line - Cancer                                                      Xiang et al., *PLOS ONE,* 2012             
                      24                          HMLE-Twist-ER cells                                                              Cell line - Cancer                                                      Cieply et al., *Cancer Res.*, 2012         
                      25                          MSP (mesenchymal sub-population) cells obtained from HMLE cells                  Cell line - Cancer                                                      Farris et al., *Mol Cancer Res*. 2016      
                      26                          OVCA429 (ovarian cystadenocarcinoma; intermediate epithelial \[IE\] phenotype)   Cell line - Cancer                                                      Chung et al., *Scientific Reports*, 2016   
                      27                          LNCaP (human prostate carcinoma cells)                                           Cell line - Cancer                                                      Paltoglou et al., *Cancer Res*. 2017       
  **Gene**            **Species**                 **Dataset**                                                                      **Tissue/Cell line**                                                    **Classification/Origin**                  **Reference**
  *Grhl3*             *Mus musculus*              28                                                                               Embryonic day 18.5 (E18.5) embryo backskin                              Primary Epithelia                          Yu et al., *Dev. Biol*., 2006
                      29                          E14.5 Bladder                                                                    Primary Epithelia                                                       Yu et al., *EMBO J*, 2009                  
                      30                          E16.5 Bladder                                                                    Primary Epithelia                                                       Yu et al., *EMBO J*, 2009                  
                      31                          E18.5 Bladder                                                                    Primary Epithelia                                                       Yu et al., *EMBO J*, 2009                  
                      32                          E14.5 Skin                                                                       Primary Epithelia                                                       Gordon et al., J *Clin. Invest*., 2014     
                      33                          E16.5 Skin                                                                       Primary Epithelia                                                       Gordon et al., J *Clin. Invest*., 2014     
                      34                          E18.5 Skin                                                                       Primary Epithelia                                                       Gordon et al., J *Clin. Invest*., 2014     
                      35                          Adult Skin                                                                       Primary Epithelia                                                       Gordon et al., J *Clin. Invest*., 2014     
                      36                          Adult Skin                                                                       Primary Epithelia                                                       Gordon et al., J *Clin. Invest*., 2014     
                      37                          Adult Skin                                                                       Primary Epithelia                                                       Gordon et al., J *Clin. Invest*., 2014     
  *Grhl3*             *Homo sapiens*              38                                                                               NHEK (Neonatal Human Epidermal Keratinocytes) cells                     Primary Epithelia                          Hopkin et al., *PLoS Genet*. 2012
                      39                          NHEKs and adult psoriasis skin                                                   Primary Epithelia                                                       Gordon et al., J *Clin. Invest*., 2014     
  *Grhl3-Isoform 1*   *Homo Sapiens*              40                                                                               Human Embryonic Kidney neuroepithelial cell line (HEK-293)              Cell line - Non-Cancer                     Haendeler et al., *Arter. Thromb. Vasc. Biol*., 2013
  *Grhl3-Isoform 3*   *Homo Sapiens*              41                                                                               HEK-293                                                                 Cell line - Non-Cancer                     Haendeler et al., *Arter. Thromb*. *Vasc. Biol*., 2013
  ------------------- --------------------------- -------------------------------------------------------------------------------- ----------------------------------------------------------------------- ------------------------------------------ --------------------------------------------------------
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The top 50 most differentially regulated genes in all biological contexts following modulation of *grh/Grhl* function. The overall top 50 differentially regulated (both positively and negatively) genes of *grh*/*grhl* as identified by analysis of all published Microarray and RNA-SEQ datasets. 15 out of the 50 predicted target genes had previously been validated in literature through either large-scale ChIP-SEQ genome mining experiments, or through experimental validation (highlighted in red).

  GRHL Targets                                                                                                                           
  -------------- ------------------- ---------- -------- ------------------------------------------------------------------------------- -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  1              **Tmem54**          POSITIVE   0.184    *Aue, et al. 2015,Walentin et al. 2015*                                         
  2              **Prom2**           POSITIVE   0.182    *Aue, et al. 2015,Walentin et al. 2015*                                         
  3              **Cldn4**           POSITIVE   0.148    *Chung, et al. 2016, Werth et al., 2010. Varma et al., 2012*                    *Senga, et al. 2012, Varma et al. 2012, Tanimizu and Mitaka 2013, Aue et al. 2015*
  4              **Cldn23**          POSITIVE   0.113                                                                                    
  5              **Grhl2**           POSITIVE   0.089                                                                                    
  6              **Ppl**             POSITIVE   0.0868   *Aue, Hinze et al. 2015*                                                        
  7              **Ocln**            POSITIVE   0.0777                                                                                   
  8              **Cdh1**            POSITIVE   0.0754   *Aue, et al. 2015, Chung, et al. 2016, Werth et al. 2010. Varma et al., 2012*   *Werth, et al. 2010. Pyrgaki, et al. 2011, Xiang, et al. 2012, Gao, et al. 2013, Tanimizu and Mitaka 2013, Chung, et al. 2016, Nishino, Takano et al. 2017, Pan, et al. 2017*
  9              **Krt7**            POSITIVE   0.0752                                                                                   
  10             **Tslp**            POSITIVE   0.0741                                                                                   
  11             **Rab15**           POSITIVE   0.0708   *Walentin et al. 2015*                                                          
  12             **Gm19601**         NEGATIVE   0.069                                                                                    
  13             **Lad1**            POSITIVE   0.0661   *Walentin et al. 2015*                                                          
  14             **Gm3579**          NEGATIVE   0.065                                                                                    
  15             **Rab25**           POSITIVE   0.0631   *Aue, et al. 2015*                                                              *Senga, et al. 2012*
  16             **Epcam**           POSITIVE   0.0618   *Chung, et al. 2016*                                                            *Xiang, et al. 2012*
  17             **Snx31**           POSITIVE   0.0607                                                                                   
  18             **Slc6a19**         NEGATIVE   0.0579                                                                                   
  19             **Zasp66**          NEGATIVE   0.0578                                                                                   
  20             **Ap1m2**           POSITIVE   0.0576                                                                                   
  21             **Sfn**             POSITIVE   0.0565                                                                                   
  22             **IL36RN**          POSITIVE   0.0562                                                                                   
  23             **2310001H18Rik**   POSITIVE   0.0562                                                                                   
  24             **Il17re**          POSITIVE   0.0558                                                                                   
  25             **Macc1**           POSITIVE   0.0558                                                                                   
  26             **Evpl**            POSITIVE   0.055                                                                                    
  27             **Gm20305**         NEGATIVE   0.0547                                                                                   
  28             **Aldh1a3**         POSITIVE   0.0538                                                                                   
  29             **Tacstd2**         POSITIVE   0.0531   *Chung, et al. 2016*                                                            
  30             **Sprr1a**          POSITIVE   0.0528                                                                                   
  31             **St14**            POSITIVE   0.0525   *Chung, et al. 2016*                                                            
  32             **Rbbp8**           POSITIVE   0.0521                                                                                   
  33             **Tmprss11b**       POSITIVE   0.0519                                                                                   
  34             **Cldn7**           POSITIVE   0.0515                                                                                   
  35             **CG10345**         NEGATIVE   0.0501                                                                                   
  36             **Sod3**            NEGATIVE   0.05                                                                                     
  37             **CG12480**         NEGATIVE   0.0499                                                                                   
  38             **Esrp1**           POSITIVE   0.0499   *Chung, et al. 2016*                                                            *Xiang, et al. 2012*
  39             **Prss22**          POSITIVE   0.0497   *Aue, et al. 2015*                                                              
  40             **Cyp2b19**         NEGATIVE   0.0497                                                                                   
  41             **Car6**            NEGATIVE   0.0497                                                                                   
  42             **Car2**            POSITIVE   0.0495                                                                                   
  43             **Fmo2**            NEGATIVE   0.0493                                                                                   
  44             **Elovl1**          NEGATIVE   0.0492                                                                                   
  45             **Elovl7**          NEGATIVE   0.0492                                                                                   
  46             **Defb3**           POSITIVE   0.0488                                                                                   
  47             **Spint1**          POSITIVE   0.0481   *Chung, et al. 2016, Walentin et al. 2015*                                      *Walentin, et al. 2015, Matsushita, et al. 2018*
  48             **Prss8**           POSITIVE   0.0481   *Chung, et al. 2016*                                                            
  49             **Cldn6**           POSITIVE   0.0481                                                                                   
  50             **Gsta2**           NEGATIVE   0.0479                                                                                   
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Gene Ontology (GO) analysis of the most differentially regulated cellular processes in all biological contexts, following modulation of *grh/Grhl* function. Functional Gene Ontology (GO) annotations are over-represented among the 200 genes positively regulated by *grh/grhl,* with the highest evidence of regulation across all species (highest fold change score aggregated over all the datasets).

  Source   Term Name                                                                       Term ID      n of Term Genes   n of Query Genes   n of Common Genes   Corrected *p* Value
  -------- ------------------------------------------------------------------------------- ------------ ----------------- ------------------ ------------------- ---------------------
  BP       biological adhesion                                                             GO:0022610   1351              80                 18                  1.69 × 10^−2^
  BP       cell adhesion                                                                   GO:007155    1343              80                 18                  1.56 × 10^−2^
  BP       cell-cell adhesion                                                              GO:0098609   776               79                 14                  6.29 × 10^−3^
  BP       cell-cell adhesion via plasma membrane adhesion molecules                       GO:0098742   245               79                 10                  1.43 × 10^−4^
  BP       calcium-independent cell-cell adhesion via plasma membrane adhesion molecules   GO:0016338   23                79                 6                   9.48 × 10^−7^
  BP       developmental process                                                           GO:0032502   6212              78                 45                  3.91 × 10^−3^
  BP       anatomical structure development                                                GO:0048856   7793              78                 44                  1.43 × 10^−3^
  BP       tissue development                                                              GO:0009888   1926              66                 27                  6.12 × 10^−8^
  BP       epithelium development                                                          GO:0060429   1218              77                 26                  8.22 × 10^−10^
  BP       epidermis development                                                           GO:0008544   459               77                 19                  2.62 × 10^−11^
  BP       multicellular organismal process                                                GO:0032501   7414              74                 48                  4.19 × 10^−3^
  BP       multicellular organism development                                              GO:0007275   5321              78                 41                  3.72 × 10^−3^
  BP       system development                                                              GO:0048731   4760              78                 40                  5.09 × 10^−4^
  BP       animal organ development                                                        GO:0048513   3428              77                 35                  2.65 × 10^−5^
  BP       skin development                                                                GO:0043588   412               77                 21                  1.18 × 10^−14^
  BP       water homeostasis                                                               GO:0030104   69                77                 5                   2.14 × 10^−2^
  BP       epithelial cell differentiation                                                 GO:0030855   759               77                 19                  1.83 × 10^−7^
  BP       epithelial cell differentiation involved in embryonic placenta development      GO:0060671   3                 25                 2                   1.39 × 10^−2^
  BP       epidermal cell differentiation                                                  GO:0009913   353               77                 16                  1.13 × 10^−9^
  BP       keratinocyte differentiation                                                    GO:0030216   299               77                 16                  8.72 × 10^−11^
  BP       keratinization                                                                  GO:0031424   224               77                 15                  2.25 × 10^−11^
  BP       cornification                                                                   GO:0070268   111               73                 11                  8.16 × 10^−10^
  BP       multicellular organismal water homeostasis                                      GO:0050891   64                77                 5                   1.48 × 10^−2^
  BP       regulation of water loss via skin                                               GO:0033561   22                77                 5                   5.79 × 10^−5^
  BP       establishment of skin barrier                                                   GO:0061436   20                77                 5                   3.43 × 10^−5^
  BP       epithelial cell morphogenesis                                                   GO:0003382   32                25                 3                   2.65 × 10^−2^
  BP       embryonic placenta morphogenesis                                                GO:0060669   25                31                 3                   2.17 × 10^−2^
  BP       labyrinthine layer morphogenesis                                                GO:0060713   21                31                 3                   1.26 × 10^−2^
  BP       branching involved in labyrinthine layer morphogenesis                          GO:0060670   12                31                 3                   2.11 × 10^−3^
  BP       epithelial cell morphogenesis involved in placental branching                   GO:0060672   3                 25                 2                   1.39 × 10^−2^
  BP       peptide cross-linking                                                           GO:0018149   59                64                 5                   3.86 × 10^−3^
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Conservation of differentially regulated genes between mouse, *Drosophila* and human across all biological contexts, following modulation of *grh/Grhl* function.

  Grhl Targets - Mus Musculus                                                                                                                                    
  ----------------------------- --------------- ---------- -------- ----------------------- ------ ---------- -------- ----------------------- ------ ---------- ---------
  1                             Prom2           Positive   0.163    prominin-like                                      PROM2                   361    Positive   0.0116
  2                             Tmem54          Positive   0.154    *No known orthologue*                              TMEM54                  1062   Positive   0.0178
  3                             Cldn4           Positive   0.116    *No known orthologue*                              CLDN4                   28     Positive   0.0264
  4                             Cldn23          Positive   0.106    *No known orthologue*                              CLDN23                                    
  5                             Ppl             Positive   0.0812   shot                                               PPL                     110    Positive   0.0187
  6                             Grhl2           Positive   0.0752   grh                     577    Positive   0.0323   GRHL2                   159    Positive   0.0165
  7                             Rab15           Positive   0.0663   RabX4                                              RAB15                                     
  8                             Ocln            Positive   0.0655   Su(Tpl)                                            OCLN                    1141   Positive   0.00717
  9                             Gm19601         Negative   0.0645   *No known orthologue*                              POLR2K \*                                 
  10                            Tslp            Positive   0.064    *No known orthologue*                              TSLP                    1957   Positive   0.00534
  11                            Gm3579          Negative   0.0608   *No known orthologue*                              *No known orthologue*                     
  12                            Cdh1            Positive   0.0592   CadN2                                              CDH1                    138    Positive   0.0177
  13                            Snx31           Positive   0.0568   CG5734                                             SNX31                                     
  14                            Slc6a19         Negative   0.0542   CG43066                                            SLC6A19                                   
  15                            2310001H18Rik   Positive   0.0526   *No known orthologue*                              *No known orthologue*                     
  16                            Il17re          Positive   0.0522   *No known orthologue*                              IL17RE                                    
  17                            Evpl            Positive   0.0514   shot                                               EVPL                    2179   Positive   0.00501
  18                            Gm20305         Negative   0.0512   *No known orthologue*                              *No known orthologue*                     
  19                            Lad1            Positive   0.0508   Nuak1                                              LAD1                    412    Positive   0.0102
  20                            Aldh1a3         Positive   0.0503   CG31075                                            ALDH1A3                 1528   Positive   0.00614
  21                            Sprr1a          Positive   0.0494   CG17377                                            SPR1A                                     
  22                            Rbbp8           Positive   0.0487   *No known orthologue*                              RBBP8NL                                   
  23                            Tmprss11b       Positive   0.0485   CG11836                                            TMPRSS2                                   
  24                            Sod3            Negative   0.0468   CG5948                                             SOD3                                      
  25                            Cyp2b19         Negative   0.0465   Cyp18a1                                            CYP2B6                                    
  26                            Car6            Negative   0.0464   CAH7                    582    Positive   0.0323   CA6                                       
  27                            Car2            Positive   0.0463   CAH1                    590    Positive   0.0323   CA2                                       
  28                            Fmo2            Negative   0.0461   Fmo-2                                              FMO2                                      
  29                            Defb3           Positive   0.0456   *No known orthologue*                              HBETAD3                                   
  30                            Rab25           Positive   0.0453   Rab11                                              RAB25                   241    Positive   0.0137
  31                            Prss8           Positive   0.045    CG16749                                            PRSS8                                     
  32                            Cldn6           Positive   0.045    *No known orthologue*                              CLDN6                                     
  33                            Gsta2           Negative   0.0448   GstS1                                              GSTA1/2/3/5                               
  34                            Aox4            Negative   0.0446   ry                                                 AOX1                                      
  35                            Tmprss13        Positive   0.0441   Sb                                                 TMPRSS13                5      Positive   0.0346
  36                            Smpdl3b         Positive   0.0437   CG32052                                            SMPDL3B                                   
  37                            Ap1m2           Positive   0.0434   AP-1mu                                             AP1M2                   464    Positive   0.0105
  38                            Pax8            Negative   0.0433   sv                                                 PAX8                                      
  39                            Klk6            Positive   0.0433   CG12951                                            KLK6                    176    Positive   0.0157
  40                            Il33            Positive   0.0425   *No known orthologue*                              IL33                                      
  41                            Fabp5           Positive   0.0424   fabp                                               FABP5                                     
  42                            Sfn             Positive   0.0419   14-3-3zeta                                         SFN                     418    Positive   0.0109
  43                            Cldn1           Positive   0.0417   *No known orthologue*                              CLDN1                   442    Negative   0.0108
  44                            Slpi            Positive   0.041    CG5639                                             SLPI                                      
  45                            Unc93a          Negative   0.0409   CG4928                  1219   Negative   0.041    UNC93A                                    
  46                            Krt6b           Positive   0.0408   LamC                                               KRT6B                                     
  47                            Macc1           Positive   0.0399   *No known orthologue*                              MACC1                                     
  48                            Rptn            Positive   0.0393   *No known orthologue*                              RPTN                    79     Positive   0.0203
  49                            Gsta1           Negative   0.039    *No known orthologue*                              GSTA1                                     
  50                            9930013L23Rik   Positive   0.0387   *No known orthologue*                              CEMIP                                     
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The top 50 most differentially regulated genes in primary epithelia following modulation of *grh/Grhl* function. Orthologues of the genes highlighted in red were screened and validated in subsequent Q-RT-PCR experiments in *grhl3^-/-^* zebrafish.

  Rank   Gene            Regulation   Normalised Score
  ------ --------------- ------------ ------------------
  1      Cldn23          POSITIVE     0.0954
  2      Ppl             POSITIVE     0.0693
  3      Prom2           POSITIVE     0.0689
  4      Gm19601         NEGATIVE     0.0689
  5      Tslp            POSITIVE     0.0684
  6      Gm3579          NEGATIVE     0.065
  7      Ocln            POSITIVE     0.0633
  8      Slc6a19         NEGATIVE     0.0579
  9      2310001H18Rik   POSITIVE     0.0562
  10     Gm20305         NEGATIVE     0.0547
  11     Aldh1a3         POSITIVE     0.0538
  12     Tmprss11bnl     POSITIVE     0.0519
  13     Snx31           POSITIVE     0.0517
  14     Sod3            NEGATIVE     0.05
  15     Cyp2b19         NEGATIVE     0.0496
  16     Car6            NEGATIVE     0.0496
  17     Cldn4           POSITIVE     0.0494
  18     Fmo2            NEGATIVE     0.0493
  19     Defb3           POSITIVE     0.0488
  20     Gsta2           NEGATIVE     0.0479
  21     Aox4            NEGATIVE     0.0476
  22     Evpl            POSITIVE     0.047
  23     Klk6            POSITIVE     0.0462
  24     Il33            POSITIVE     0.0455
  25     Cldn1           POSITIVE     0.0446
  26     Slpi            POSITIVE     0.106
  27     Unc93a          NEGATIVE     0.106
  28     Krt6b           POSITIVE     0.105
  29     Sprr1a          POSITIVE     0.105
  30     Rptn            POSITIVE     0.102
  31     Gsta1           NEGATIVE     0.101
  32     Cemip           POSITIVE     0.0999
  33     Fabp7           POSITIVE     0.0991
  34     Adh6a           NEGATIVE     0.0985
  35     Wfdc12          POSITIVE     0.0961
  36     Fxyd4           POSITIVE     0.096
  37     Krt78           NEGATIVE     0.0956
  38     Tmem54          POSITIVE     0.0953
  39     Gldc            NEGATIVE     0.0951
  40     Gdpd1           NEGATIVE     0.0945
  41     Slurp1          POSITIVE     0.0939
  42     Hyal4           NEGATIVE     0.0934
  43     Lce3f           POSITIVE     0.0933
  44     Unc93a2         NEGATIVE     0.0932
  45     Sptlc3          POSITIVE     0.0926
  46     Pglyrp1         NEGATIVE     0.0924
  47     Gm10639         NEGATIVE     0.0915
  48     Gdpd3           NEGATIVE     0.0912
  49     Cldnb8          POSITIVE     0.0912
  50     Tmprss4         POSITIVE     0.0894
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###### 

The top 50 most differentially regulated genes in cancer cell lines following modulation of *grh/Grhl* function.

  Rank   Gene              Regulation   Normalised Score
  ------ ----------------- ------------ ------------------
  1      ALOX15            POSITIVE     0.045
  2      CCDC88A           NEGATIVE     0.0405
  3      FAT4              NEGATIVE     0.0345
  4      EPCAM             POSITIVE     0.0345
  5      IL36RN            POSITIVE     0.0345
  6      AHSG              NEGATIVE     0.0345
  7      Krt7              POSITIVE     0.0345
  8      Sele              NEGATIVE     0.0345
  9      AIM1              POSITIVE     0.0285
  10     CD24              POSITIVE     0.0277
  11     ALOXE3            POSITIVE     0.0274
  12     SOD1              NEGATIVE     0.0274
  13     ITGB6             POSITIVE     0.0274
  14     SERPINE1          NEGATIVE     0.0274
  15     NOX5              POSITIVE     0.0274
  16     ALB               NEGATIVE     0.0274
  17     Epcam             POSITIVE     0.0274
  18     Ptges             NEGATIVE     0.0274
  19     KRT19             POSITIVE     0.0263
  20     TYMS              NEGATIVE     0.0248
  21     ALOX12P2          POSITIVE     0.0239
  22     Cat               NEGATIVE     0.0239
  23     FGF2              NEGATIVE     0.0239
  24     CRISP3            POSITIVE     0.0239
  25     SYN3              NEGATIVE     0.0239
  26     Cldn4             POSITIVE     0.0239
  27     Otop1             NEGATIVE     0.0239
  28     SLC1A6            POSITIVE     0.0217
  29     NQO1              NEGATIVE     0.0217
  30     TMPRSS13          POSITIVE     0.0217
  31     ATOH8             NEGATIVE     0.0217
  32     Cldn7             POSITIVE     0.0217
  33     Xdh               NEGATIVE     0.0217
  34     NCF2 (p67-PHOX)   POSITIVE     0.0202
  35     GLUD1             NEGATIVE     0.0202
  36     ITGA2             POSITIVE     0.0202
  37     SMARCA1           NEGATIVE     0.0202
  38     ALDH3B2           POSITIVE     0.0202
  39     BRSK1             NEGATIVE     0.0202
  40     Lamc2             POSITIVE     0.0202
  41     Olfr1372-ps1      NEGATIVE     0.0202
  42     SOD2              POSITIVE     0.019
  43     ITGB8             POSITIVE     0.019
  44     CDH2              NEGATIVE     0.019
  45     A2ML1             POSITIVE     0.019
  46     TMEM45A           NEGATIVE     0.019
  47     Tmem54            POSITIVE     0.019
  48     Dnahc6            NEGATIVE     0.019
  49     CDH1              POSITIVE     0.0189
  50     GALNT3            POSITIVE     0.0188

[^1]: These authors contributed equally to this work.
